Position SummaryThe Director Market Access will be responsible for leading reimbursement & HTA submissions across target markets in EMEA. The role spans Evidence, Value and Access domains and will cover a diverse set of challenges and processes across various geographies. This individual will work closely with the Global Market Access team & external consultants, making use of clinical data and economic models, to establish appropriate justifications for reimbursement and coverage. This is expected to include using cost effectiveness models and value dossiers for reimbursement applications and product positioning. As part of this effort, the preparing and updating of national reimbursement roadmaps and HTA submission files for Recor products, services, and industry trends will be critical. In addition, ensuring robust health economic data analyses as it relates to the EMEA region will be very important in advancing this novel new therapy. The role will also incorporate communication to and with third party payers, government entities and other market access partners and trade associations.This job does not currently have supervisory responsibilities.Responsibilities and DutiesResponsibility for the reimbursement submissions strategy and execution across multiple / various countries in the regionResponsibility for the development of health cost economic analysis tools (spreadsheets and economic models) for Recor partners and internal organizationManaging updates to the core value dossiers across the EMEA region for Recor productsFoster a close and effective working relationship across all relevant departments and teams, especially sales & marketing, regulatory and clinical / scientific affairsFacilitate Key Opinion Leader (KOL) and Clinical Society conversations as requiredCreate and sustain Advisory Boards and Expert Working Groups to drive market access objectives in countries across EuropeIdentify opportunities and threats from shifts in policy landscape, health technology assessments or other value assessments across EuropeResponsibility for representing ReCor at national-level trade associations in Europe and highlighting key developments which could impact the marketResponsibility for engagement with HTA processes involving ReCor products and services in Europe and managing submissions & consultation processes, including clinician and patient feedbackResponsibility for driving updates to country-level position statements and guidelines to positively include Recor products and servicesKeep up to date on clinical trials, both investigator initiated and external studies, that can be used to improve clinical and health economic value messaging for Recor Medical products or categoriesPrepare and update Market Access presentations for use by Recor partners and internal organizationOversee and / or assist in the writing of articles and preparation of materials to be used professionally by RecorThis position assumes and performs other duties as assigned by the Vice President, Market AccessYour profileMaster’s Degree required. Master’s (MA; MSc; MPH, MBA) in relevant field (Health Economics, Health Policy, Public Health, Business) is requiredMinimum of 10+ years related experience and / or training; or equivalent combination of education and experienceProven expertise in Market Access and reimbursement with at least last 5 years consistent of hands‑on experience navigating reimbursement pathways for medical devices across the five key European markets (Germany, UK, Italy, Spain, France). Beyond established national frameworks the ideal candidate brings a strong track record in developing alternative access solutions with payer and innovative funding models.Strong Leadership capabilitiesMust be able to communicate effectively and fluently in English, and ideally 1 or 2 other European languages. Ability to read and interpret documents such as safety rules, operating and maintenance instructions, and procedure manuals. Ability to write routine reports and correspondence. Ability to speak effectively before groups of customers or employees of organization.Analytical competencies to structure complex issues, synthesize key points, communicate and present in an easily understandable mannerStrong organization and planning skillsSelf‑motivated with excellent time management skillsAbility to work effectively with minimum supervision essentialAbility to grow with the organization and willingness to assume additional responsibilities over timeCompetence and credibility to build relationships of trust with physicians and associated professional staff at clinical centersStrong communication, interpersonal and problem‑solving skillsAbility to forge strong working relationships with sales and marketingStrong computer skills with a working knowledge of Word, Excel, PowerPoint & OutlookEnthusiastic, positive and professional team playerIt is anticipated that this role will require travel around the EMEA region ~50% of the time, with occasional trans‑Atlantic travel in addition to regional travel commitmentsPrior experience in Cardiology would be advantageous but not essentialPrior experience of launching a disruptive technology and establishing a novel therapeutic approach preferredAbout usRecor Medical Ltd. / Recor Medical Europe GmbH, headquartered in Palo Alto, CA, is an innovative medical technology company focused on transforming the management of hypertension, the leading cardiovascular risk factor in the world. Recor has pioneered the innovative, minimally invasive use of ultrasound in renal denervation to lower blood pressure in patients with hypertension. The company is focused on investing in high quality product development efforts, as well as rigorous clinical studies to create a strong foundation for future clinical adoption.Recor Medical is a wholly‑owned subsidiary of Otsuka Medical Devices Co., Ltd. Otsuka Medical Devices focuses on the global development and commercialization of endovascular therapies that provide new therapeutic options in areas where patient needs cannot be met through pharmaceutical treatment. Otsuka Medical Devices Co., Ltd. is a subsidiary of Otsuka Holdings Co., Ltd., a leading global healthcare group listed on the Tokyo Stock Exchange (JP 4578). With operations in pharmaceuticals, nutraceuticals, medical devices and other health‑related businesses, the group generated worldwide sales of approximately US$13 billion in the fiscal year ending December 2021 and has a market capitalization of app. US$19 billion.Recor Medical EMEA http : / / www.otsuka.com / en / #J-18808-Ljbffr